These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Mehran R; Brodie B; Cox DA; Grines CL; Rutherford B; Bhatt DL; Dangas G; Feit F; Ohman EM; Parise H; Fahy M; Lansky AJ; Stone GW Am Heart J; 2008 Jul; 156(1):44-56. PubMed ID: 18585496 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial). Valencia R; Price MJ; Sawhney N; Lee SS; Wong GB; Gollapudi RR; Banares M; Schatz RA; Teirstein PS Am J Cardiol; 2007 Oct; 100(7):1099-102. PubMed ID: 17884370 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of the antithrombotlic effect and safety between intravenous nadroparin and unfractionated heparin in patients undergoing percutaneous coronary intervention]. Zhu JH; Qiu YG; Chen JZ; Zhang FR; Fu GS; Shen FR; Huang WJ; Wang JA; Zhao LL; Tao QM; Zheng LR Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):335-9. PubMed ID: 15932664 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis. Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233 [TBL] [Abstract][Full Text] [Related]
12. Low-dose heparin for elective percutaneous coronary intervention. Lee MS; Oyama J; Iqbal Z; Tarantini G J Interv Cardiol; 2014 Feb; 27(1):58-62. PubMed ID: 24152197 [TBL] [Abstract][Full Text] [Related]
13. Assessment of clinical outcomes related to early discharge after elective percutaneous coronary intervention: COED PCI. Muthusamy P; Busman DK; Davis AT; Wohns DH Catheter Cardiovasc Interv; 2013 Jan; 81(1):6-13. PubMed ID: 22745040 [TBL] [Abstract][Full Text] [Related]
14. The REDUCED (a RandomisED stUdy Comparing standard systemic anticoagulation thErapy to low Dose intracoronary anticoagulation therapy for elective percutaneous coronary intervention) trial. A novel pharmacologic regime for elective percutaneous coronary intervention. Ari H; Kivaç E; Ari S; Emlek N; Cetinkaya S; Celiloğlu N; Sarigul OY; Aydin C; Akkaya M; Koca V; Bozat T; Gurdogan M Acta Cardiol; 2014 Dec; 69(6):619-27. PubMed ID: 25643432 [TBL] [Abstract][Full Text] [Related]
15. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR; N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147 [TBL] [Abstract][Full Text] [Related]
16. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802 [TBL] [Abstract][Full Text] [Related]
17. Coronary intervention without a safety net. Dauerman HL J Am Coll Cardiol; 2008 Oct; 52(16):1299-301. PubMed ID: 18929240 [No Abstract] [Full Text] [Related]
18. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Rubboli A; Milandri M; Castelvetri C; Cosmi B Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950 [TBL] [Abstract][Full Text] [Related]
19. Provisional stenting for multivessel PCI. Han B; Liu L; Aboud M; Nahir M; Hasin Y Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615 [TBL] [Abstract][Full Text] [Related]
20. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]